Tattoli Mark Damian (CIK 1872069) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Sell CLB (14,310 shares), Buy CLB (24,952 shares), Sell CLB (276 shares), Buy CLB (700 shares), Sell CLB (99 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Sell | 14,310 | $229,389 |
| 2026-01-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Buy | 24,952 | $0 |
| 2025-10-02 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Sell | 276 | $3,472 |
| 2025-10-02 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Buy | 700 | $0 |
| 2025-08-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Sell | 99 | $1,042 |
| 2025-08-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Buy | 250 | $0 |
| 2025-05-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Sell | 99 | $1,156 |
| 2025-05-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Buy | 250 | $0 |
| 2025-05-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Sell | 79 | $923 |
| 2025-05-05 | Core Laboratories Inc. /DE/ (CLB) | SVP, Gen Counsel & Secretary | Buy | 200 | $0 |
Source: SEC Form 4 filings · as of 2026-01-05